Inversion of genetic predisposition to carcinogenesis in liver of two lines of mice selected for resistance (Car-R) or susceptibility (Car-S) to skin carcinogenesis

Cancer Letters

Volumn 132, Issue 1-2, 1998, Pages 81-90

  Périn, François ^a   Périn Roussel, Odette ^a   Taras Valéro, Danièle ^a   Mouton, Denise ^a   Covelli, Vincenzo ^b   Zajdela, François ^a  

^a INSTITUT CURIE   (France)

^b ENEA   (Italy)

Author keywords

5,9 Dimethyldibenzo c,g carbazole; 32P Postlabeling assay; Genetic predisposition to cancer; Liver carcinogenesis; Organ specificity

Indexed keywords

CARCINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENETIC PREDISPOSITION; ISOTOPE LABELING; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TISSUE SPECIFICITY;

ANIMALS; CARBAZOLES; CARCINOGENS; DISEASE SUSCEPTIBILITY; DNA ADDUCTS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; ORGAN SIZE; SKIN NEOPLASMS;

EID: 0032561448     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00161-X     Document Type: Article

References (44)

1. DiGiovanni D., Slaga T.J., Boutwell R.K. Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CD-1 mice. Carcinogenesis. 1:1980;381-389.
2. P. Grasso, J. Hardy, Strain differences in natural incidence and response to carcinogenesis, in: W.H. Buttler, P.M. Newberne (Eds.), Mouse Hepatic Neoplasia, Elsevier, Amsterdam, 1975, pp. 111-122.
3. Shimkin M.B., Stoner G.D. Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res. 21:1975;1-58.
4. Hennings H., Devor D., Wenk M.L., Slaga T.J., Former B., Colburn N.H., Bowden G.T., Elgjo K., Yuspa S.H. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene or N-methyl-N′-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res. 41:1981;773-779.
5. Bangrazi C., Mouton D., Neveu T., Saran A., Covelli V., Doria G., Biozzi G. Genetics of chemical carcinogenesis. I. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogenesis. 11:1990;1711-1719.
6. Cope F.O., Wagner F.J., Conway T., Burns P.D., Johnston D., Murphy P., Triggs G., Wille J. Tumorigenic and molecular characterization of novel phorbol ester-resistant and -sensitive lines of mice. Mol. Carcinogen. 1:1988;116-124.
7. Malkinson A.M. The genetic basis of susceptibility to lung tumors in mice. Toxicology. 54:1989;241-271.
8. 3H/HeJ inbred mice. Carcinogenesis. 7:1986;1701-1707.
9. Dragani T.A., Manenti G.J., Della Porta G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 51:1991;6290-6303.
10. Demant P. Genetic resolution of susceptibility to cancer: new perspectives. Cancer Biol. 3:1992;159-166.
11. Drinkwater N.R., Bennet L.M. Genetic control of carcinogenesis in experimental animals. Prog. Exp. Tumor Res. 33:1991;1-20.
12. Pioli C., Saran A., Mouton D., Troiani C., Doria G., Covelli V., Neveu T., Biozzi G. Genetics of chemical carcinogenesis. II Papilloma induction and malignant conversion in susceptible (Car-S) and resistant (Car-R) lines of mice produced by bidirectional selective breeding and in their (Car-S × Car-R) F1 hybrids. Carcinogenesis. 15:1994;2629-2635.
13. Saran A., Bouthillier Y., Pioli C., Mouton D., Covelli V., Doria G., Neveu T., Biozzi G. Genetics of chemical carcinogenesis. III Tissue-specificity of the genes controlling susceptibility and resistance to skin carcinogenesis in the mouse. Carcinogenesis. 17:1996;2463-2468.
14. Warshawsky D. Environmental sources, carcinogenicity, mutagenicity, metabolism and DNA binding of nitrogen and sulfur heterocyclic aromatics. Environ. Carcinogen. Ecotox. Rev. 10:1992;1-71.
15. Valero D., Perin F., Plessis M.J., Zajdela F. Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyldibenzocarbazole-induced hepatocarcinogenesis in mice. Cancer Lett. 27:1985;181-197.
16. Perin-Roussel O., Barat N., Zajdela F., Perin F. Tissue specific differences in adduct formation by hepatocarcinogenic and sarcomagenic derivatives of 7H-dibenzo[c,g]carbazole in mouse parenchymal and nonparenchymal liver cells. Environ. Mol. Mutagen. 29:1997;346-356.
17. Perin-Roussel O., Perin F., Barat N., Plessis M.J., Zajdela F. Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivatives with hepatic mitochondrial and nuclear DNA in mouse. Environ. Mol. Mutagen. 25:1995;202-210.
18. 32P-Labeling test for DNA damage. Proc. Natl. Acad. Sci. USA. 78:1981;6126-6129.
19. Perin F., Perin-Roussel O., Barat N., Plessis M.J., Saran A., Pioli P., Covelli V., Biozzi G., Mouton D. Comparison of 7,12-dimethylbenz(a)anthracene-DNA adduction in the epidermis of two lines of mice selected for resistance (Car-R) or susceptibility (Car-S) to skin carcinogenesis. Cancer Res. 54:1994;4635-4640.
20. Morse M.A., Baird W.M., Carlson G.P. Distribution covalent binding and DNA adduct formation of 7,12-dimethylbenz(a)anthracene in Sencar and BALB/c mice following topical and oral administration. Cancer Res. 47:1987;4571-4575.
21. Elmets C.A., Zaidi S.L., Bickers D.A., Mukhtar H. Immunogenetic influences in the initiation stage of cutaneous chemical carcinogenesis pathway. Cancer Res. 52:1992;6108-6109.
22. Perin F., Dufour M., Mispelter J., Ekert B., Kunneke C., Oesch F., Zajdela F. Heterocyclic polycyclic aromatic hydrocarbon carcinogenesis: 7H-dibenzo[c,g]carbazole metabolism by microsomal enzymes from mouse and rat liver. Chem.-Biol. Interact. 35:1981;267-284.
23. Valero D., Perin F., Zajdela F. Binding of 5,9-dimethyl-dibenzo[c,g]carbazole, a potent hepatocarcinogen, to mouse hepatic cytosolic proteins. Carcinogenesis. 4:1983;1333-1340.
24. Rutenburg A.M., Kim H., Fischbein J.W., Hanker J.S., Wasserkrug H.L., Seligman A.M. Histochemical and ultrastructural demonstration of γ-glutamyltranspeptidase activity. J. Histochem. Cytochem. 17:1969;517-526.
25. Gupta R.C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. USA. 81:1984;6943-6947.
26. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 7:1986;1543-1551.
27. 32P-Postlabeling analysis of nonradioactive aromatic carcinogen-DNA adducts. Carcinogenesis. 3:1982;1081-1092.
28. 32P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 6:1985;1117-1126.
29. G. Jones, W.H. Buttler, Morphology of spontaneous and induced neoplasia, in: W.H. Buttler, P.M. Newberne (Eds.), Mouse Hepatic Neoplasia, Elsevier, Amsterdam, 1975, pp. 21-59.
30. B.H. Huebner, M.E. Gershwin, S.W. French, E. Meierkensy, P. Dunn, L.S. Hsiech, Mouse hepatic neoplasia: differences among strains and carcinogens, in: J.A. Popp (Ed.), Mouse Liver Neoplasia Current Perspectives, Hemisphere, Washington, DC, 1984, pp. 115-143.
31. Gariboldi M., Manenti G., Canzian F., Falvella F.S., Pierotti M.A., Della Porta G., Binelli G., Dragani T.A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 53:1993;209-211.
32. Manenti G., Binelli G., Gariboldi M., Canzian F., De Gregorio L., Falvella F.S., Dragani T.A., Pierotti M.A. Multiple loci aspect genetic predisposition to hepatocarcinogenesis in mice. Genomics. 23:1994;118-124.
33. Lee G.H., Bennett L.M., Carabeo R.A., Drinkwater N.R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics. 139:1995;387-395.
34. Steinberg P., Lafranconi W.M., Oesch F. The distribution of carcinogen metabolizing enzymes in the mouse liver: comparison of parenchymal and nonparenchymal cell populations. Arch. Toxicol. 10(Suppl.):1987;148-156.
35. Harada N., Utsumi T., Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exon 1 in carcinogenesis. Proc. Natl. Acad. Sci. USA. 90:1993;11312-11316.
36. Dragani T.A., Manenti A., Della Porta G. Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes. J. Cancer Res. Clin. Oncol. 113:1987;223-229.
37. Schulte-Hermann R. Tumor promotion in the liver. Arch. Toxicol. 57:1985;147-158.
38. Malkinson A.M., Nesbitt M.N., Skamene E. Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: use of A×B and B×A recombinant inbred lines indicating a three-locus genetic model. J. Natl. Cancer Inst. 75:1985;971-974.
39. Massey T.E., Devereux T.R., Maronpot R.R., Foley J.F., Anderson M.W. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J×BALB/cj) mice. Carcinogenesis. 16:1995;1065-1069.
40. Pitot H.C. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 30:1990;465-500.
41. Velculescu V.E., Zhang L., Zhou W., Vogelstein J., Basrai M.A., Basset D.E., Hieter P., Vogelstein B., Kinzler K.W. Characterization of yeast transcriptome. Cell. 88:1997;243-251.
42. Zhan L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., Kinzler K.W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272.
43. Fijneman R.J.A., De Vries S.S., Jansen R.C., Demant P. Complex interactions of new quantitative trait loci, Sluc 1, Sluc 2, Sluc 3 and Sluc 4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet. 14:1996;465-467.
44. Van Wezel T., Stassen A.P.M., Moen C.J.A., Hart A.A.M., Van der Valk M.A., Demant P. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet. 14:1996;468-470.